The expression of the NPPC gene is upregulated in MPS IVA patients to compensate for growth impairment or tissue resistance to CNP, as seen in achondroplasia, hypochondroplasia, and thanatophoric dysplasia [69]. Here, CNP is linked to thanatophoric dysplasia.